TOKYO, July 23 - Takeda Pharmaceutical Co Ltd, Japan's largest drugmaker, said U.S. health authorities have extended their review of a diabetes drug combining its top-selling Actos and experimental medicine alogliptin until September. The combination...
MANILA, July 20 - Big international pharmaceutical firms in the Philippines have offered to lower prices of dozens of best-selling drugs to stop the government imposing price controls, an industry spokesman said on Monday. The...
MANILA, July 20 - Big international pharmaceutical firms doing business in the Philippines have offered to lower prices of dozens of best-selling drugs to prevent the government from imposing price controls, an industry spokesman said...
* Health threats such as H1N1 require new drugs, jabs -WHO * Ideal H1N1 vaccine would include seasonal, other viruses GENEVA, July 14 - Pharmaceutical firms need incentives, including lucrative patents, to keep creating drugs...
SHANGHAI, July 10 - Shares in China's Guilin Sanjin Pharmaceutical and Zhejiang Wanma Cable almost doubled in their debut on the Shenzhen Stock Exchange on Friday, buoyed by strong investor interest in the country's first...
SHANGHAI, July 9 - China's Guilin Sanjin Pharmaceutical Co and Zhejiang Wanma Cable Co on Thursday said they would list shares on the Shenzhen Stock Exchange on Friday, the first two initial public equity offerings...
JAKARTA, June 19 - Indonesian pharmaceutical firm PT Kalbe Farma Tbk <KLBF.JK> said on Friday it plans to hold a tender offer for 31.81 percent of the shares in its trading unit PT Enseval Putera...
SHANGHAI, June 18 - China's Guilin Sanjin Pharmaceutical Co has received a regulatory notice allowing it to go public and issue yuan-denominated A shares, the official China Securities Journal reported on its website late on...
DHAKA, June 17 - London-listed Bangladeshi drug maker Beximco Pharmaceuticals Ltd's 2008 profit rose 79 precent to around 720 million taka ($11 million), vice chairman Salman F Rahman said on Wednesday. "Enhanced and impressive growth...
* To delay European application until 2012 * Will conduct additional two-year study * Takeda shares fall 1.3 percent TOKYO, June 4 - Japan's Takeda Pharmaceutical said it would delay seeking European approval of a...